ECSP18010065A - Proceso para la producción de cannabidiol y delta-9-tetrahidrocannabinol - Google Patents
Proceso para la producción de cannabidiol y delta-9-tetrahidrocannabinolInfo
- Publication number
- ECSP18010065A ECSP18010065A ECIEPI201810065A ECPI201810065A ECSP18010065A EC SP18010065 A ECSP18010065 A EC SP18010065A EC IEPI201810065 A ECIEPI201810065 A EC IEPI201810065A EC PI201810065 A ECPI201810065 A EC PI201810065A EC SP18010065 A ECSP18010065 A EC SP18010065A
- Authority
- EC
- Ecuador
- Prior art keywords
- cannabidiol
- derivative
- compound
- tetrahidrocannabinol
- delta
- Prior art date
Links
- 229950011318 cannabidiol Drugs 0.000 title abstract 6
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 title abstract 5
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 title abstract 5
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 title abstract 5
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 title abstract 2
- -1 cannabidiol compound Chemical class 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 1
- 238000006555 catalytic reaction Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
- C07C37/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
La presente descripción se refiere a la preparación de un compuesto de cannabidiol o un derivado del mismo. El compuesto de cannabidiol o un derivado del mismo se puede preparar por medio de una reacción catalizada con ácido de un di-halo-olivetol seleccionado y sustituido adecuadamente o derivado del mismo con un alqueno cíclico seleccionado y sustituido adecuadamente para producir un compuesto de dihalo-cannabidiol o derivado del mismo. El compuesto de dihalo-cannabidiol o derivado del mismo se puede producir con alto rendimiento, alta estereoespecificidad o ambos. Luego se puede convertir en condiciones reductoras a un compuesto de cannabidiol o derivados del mismo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562191097P | 2015-07-10 | 2015-07-10 | |
| US15/199,528 US10059683B2 (en) | 2015-07-10 | 2016-06-30 | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP18010065A true ECSP18010065A (es) | 2018-05-31 |
Family
ID=57730761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECIEPI201810065A ECSP18010065A (es) | 2015-07-10 | 2018-02-09 | Proceso para la producción de cannabidiol y delta-9-tetrahidrocannabinol |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US10059683B2 (es) |
| EP (2) | EP3319952B8 (es) |
| JP (2) | JP6810842B2 (es) |
| CN (1) | CN108137526A (es) |
| AU (2) | AU2016294264B2 (es) |
| BR (1) | BR112018000497A2 (es) |
| CA (1) | CA2992043C (es) |
| CL (2) | CL2018000079A1 (es) |
| CO (1) | CO2018001290A2 (es) |
| CR (1) | CR20180094A (es) |
| DK (1) | DK3319952T3 (es) |
| EC (1) | ECSP18010065A (es) |
| ES (2) | ES3010714T3 (es) |
| HK (1) | HK1255390A1 (es) |
| IL (1) | IL256750A (es) |
| MX (1) | MX2018000354A (es) |
| MY (1) | MY182971A (es) |
| NZ (1) | NZ738925A (es) |
| PH (1) | PH12018500093A1 (es) |
| PT (1) | PT3319952T (es) |
| WO (1) | WO2017011210A1 (es) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2530001B (en) | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
| GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2531281A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| GB2539472A (en) | 2015-06-17 | 2016-12-21 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| US10059683B2 (en) * | 2015-07-10 | 2018-08-28 | Noramco, Inc. | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| GB2564383B (en) | 2017-06-23 | 2021-04-21 | Gw Res Ltd | Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex |
| US10640482B2 (en) | 2017-07-21 | 2020-05-05 | University Of South Florida | Synthesis of cannabinoids |
| GB2568929A (en) | 2017-12-01 | 2019-06-05 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| CA3089994A1 (en) | 2018-01-31 | 2019-08-08 | Canopy Holdings, LLC | Hemp powder |
| CA3091088A1 (en) * | 2018-02-13 | 2019-08-22 | Beetlebung Pharma Ltd. | Cannabinoid derivatives and conjugates and uses thereof |
| HUE060229T2 (hu) * | 2018-02-20 | 2023-02-28 | Mymd Pharmaceuticals Inc | Genetikailag módosított cannabis sativa növények és módosított kannabinoid vegyületek a kábítószer-függõség és más rendellenességek kezelésére |
| EP4620940A3 (en) | 2018-06-28 | 2025-12-17 | Symrise AG | Synthesis of (+)-cannabinoids and their therapeutic effects |
| US10736869B2 (en) | 2018-07-16 | 2020-08-11 | ECS Health Sciences, Inc. | Compositions and methods related to cannabinoids, terpenoids and essential oils |
| CN108863768A (zh) * | 2018-08-03 | 2018-11-23 | 上海华堇生物技术有限责任公司 | 3,5-二甲氧基苯甲酰氯的制备方法 |
| JP2021535203A (ja) * | 2018-08-20 | 2021-12-16 | ベッソール ファルマ、エルエルシー | 既知および新規カンナビノイドの適用 |
| WO2020051371A2 (en) * | 2018-09-05 | 2020-03-12 | Noramco, Inc. | Cannabidiol compositions having modified cannabinoid profiles |
| WO2020077153A1 (en) | 2018-10-10 | 2020-04-16 | Canopy Holdings, LLC | Synthesis of cannabigerol |
| EP3653596A1 (en) * | 2018-11-14 | 2020-05-20 | Indena S.p.A. | Continuous flow synthesis of cannabidiol |
| DE102019104563A1 (de) | 2019-02-22 | 2020-08-27 | Chiracon Gmbh | Verfahren zur Herstellung von Cannabidiol |
| CN109970516A (zh) * | 2019-03-20 | 2019-07-05 | 栾云鹏 | 一种工业化制备高纯度高收率的大麻酚类物质的合成方法 |
| US10981850B2 (en) | 2019-04-15 | 2021-04-20 | Trustees Of Boston University | One-step flow-mediated synthesis of cannabidiol (CBD) and derivatives |
| CN111943813B (zh) * | 2019-05-17 | 2023-04-14 | 上海特化医药科技有限公司 | 大麻二酚类化合物的制备方法 |
| CA3179235A1 (en) * | 2019-05-23 | 2020-11-26 | Kare Chemical Technologies Inc. | Catalytic cannabinoid processes and precursors |
| CA3142008A1 (en) * | 2019-05-31 | 2020-12-03 | Purisys Llc | Processes for the preparation of halogenated dihydroxybenzene compounds |
| EP3983367B1 (en) | 2019-06-11 | 2025-07-30 | Symrise AG | Synthesis and purification of cannabigerol and its application |
| WO2020248058A1 (en) | 2019-06-11 | 2020-12-17 | Canopy Growth Corporation | Improved methods for converting cannabidiol into delta 8-tetrahydrocannabinol |
| WO2020252277A1 (en) * | 2019-06-13 | 2020-12-17 | Isomerz, Inc. | Making delta 8 thc, delta 10 thc and/or cannabinol from cbd |
| US20220242810A1 (en) * | 2019-06-14 | 2022-08-04 | Purisys Llc | Crystalline cannabigerol |
| GB201910389D0 (en) * | 2019-07-19 | 2019-09-04 | Gw Pharma Ltd | Novel compounds, methods for their manufacture, and uses thereof |
| AU2020345656A1 (en) | 2019-09-09 | 2022-04-21 | Kare Chemical Technologies Inc. | Cannabinoid derivatives, precursors and uses |
| US11542243B1 (en) | 2019-09-26 | 2023-01-03 | FusionFarms, LLC | Method of converting delta9-THC to delta10-THC and the purification of the delta10-THC by crystallization |
| WO2021113083A1 (en) | 2019-12-06 | 2021-06-10 | JLABS Beauty LLC | Topical compositions containing rose oil and cannabidiol and methods of making and using the same |
| JP7761564B2 (ja) * | 2019-12-27 | 2025-10-28 | ベイメディカ インコーポレイテッド | カンナビクロメンおよび関連するカンナビノイドの調製法 |
| EP4089081B1 (en) * | 2020-01-08 | 2025-07-23 | Chengdu Baiyu Pharmaceutical Co., Ltd. | Tetrahydrocannabinol derivative, and preparation method therefor and medical use thereof |
| CN113087599A (zh) * | 2020-01-08 | 2021-07-09 | 成都百裕制药股份有限公司 | 大麻二酚衍生物及其制备方法和在医药上的应用 |
| WO2021139739A1 (zh) * | 2020-01-08 | 2021-07-15 | 成都百裕制药股份有限公司 | 大麻二酚衍生物及其制备方法和在医药上的应用 |
| WO2021150885A1 (en) * | 2020-01-24 | 2021-07-29 | Perkinelmer Health Sciences, Inc. | Cannabinoid derivatives |
| US10981849B1 (en) * | 2020-02-20 | 2021-04-20 | Sci Pharmtech Inc. | Method for preparing cannabinoids |
| GB202002754D0 (en) | 2020-02-27 | 2020-04-15 | Gw Res Ltd | Methods of treating tuberous sclerosis complex with cannabidiol and everolimus |
| WO2021181420A1 (en) | 2020-03-12 | 2021-09-16 | Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) | Process for the synthesis of cannabidiol and intermediates thereof |
| BR112022019616A2 (pt) | 2020-03-31 | 2022-12-06 | Phytotherapeutix Ltd | Compostos terpenofenólicos e seu uso |
| CA3179442A1 (en) | 2020-05-22 | 2021-11-25 | Brian Warrington | Compositions for treating acne and dermatological conditions |
| CN112094257B (zh) * | 2020-08-19 | 2023-08-22 | 公安部禁毒情报技术中心 | 一种△-9四氢大麻酚的制备方法 |
| CN112811980B (zh) * | 2020-12-01 | 2022-03-25 | 山东金城金奥医药科技有限公司 | 一种绿色光氧化连续制备大麻二酚中间体的方法 |
| CA3205594A1 (en) | 2020-12-17 | 2022-06-23 | Nalu Bio, Inc. | Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use |
| JP2024500187A (ja) | 2020-12-21 | 2024-01-04 | アイソセレス ファーマシューティカルズ，インコーポレイテッド | 非経口カンナビノイド配合物およびその使用 |
| US11242328B1 (en) * | 2021-02-25 | 2022-02-08 | Acid Neutral Alkaline Laboratory | Heterogeneous catalyst and method for preparation of aromatic tricyclic pyrans |
| US11242330B1 (en) * | 2021-02-25 | 2022-02-08 | Acid Neutral Alkaline Laboratory | Organic catalyst and method for preparation of aromatic tricyclic pyrans |
| US20220306598A1 (en) * | 2021-03-25 | 2022-09-29 | Precision Extraction Corporation | Method for highly selective conversion of cbd to delta-8 thc |
| GB2628746A (en) * | 2021-03-31 | 2024-10-02 | Phytotherapeutix Ltd | Terpenophenolic compounds and their use |
| US11352337B1 (en) * | 2021-06-02 | 2022-06-07 | Acid Neutral Alkaline Laboratory | Zeolite catalyst and method for preparation of aromatic tricyclic pyrans |
| CN113603568A (zh) * | 2021-07-19 | 2021-11-05 | 厦门朝阳生物工程有限公司 | 一种大麻二酚的制备方法 |
| WO2023086447A2 (en) * | 2021-11-12 | 2023-05-19 | Pureform Global, Inc. | A method for the synthesis of cannabinol |
| US20260049067A1 (en) | 2022-08-05 | 2026-02-19 | Salud & Semillas, S.L. | CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl 3 * 6H2O AS CATALYST |
| WO2024031176A1 (en) | 2022-08-11 | 2024-02-15 | Cardiol Therapeutics Inc. | Stable injectable cannabidiol formulations |
| CN117700304A (zh) * | 2022-09-01 | 2024-03-15 | 卡那比生物科学有限公司 | 一种大麻二酚的制备方法及其应用 |
| GB2642523A (en) * | 2024-07-12 | 2026-01-14 | Sonas Pharmaceuticals N I Ltd | Novel halogenated cannabinoid derivatives |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH473075A (de) | 1966-11-04 | 1969-05-31 | Theodor Dr Petrzilka | Verfahren zur Herstellung von in 2-Stellung substituierten Resorcinderivaten |
| DE4100441A1 (de) | 1991-01-09 | 1992-07-16 | Mack Chem Pharm | Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol |
| WO2001003690A1 (en) | 1999-07-12 | 2001-01-18 | Virginia Commonwealth University | Novel vasodilator cannabinoid analogs |
| EP1482917B1 (en) * | 2002-02-01 | 2019-05-08 | GW Pharma Limited | Compositions comprising cannabidiolic acid for treatment of nausea, vomiting, emesis, motion sickness or like conditions |
| GB2393182B (en) * | 2002-09-23 | 2007-03-14 | Gw Pharma Ltd | Method of preparing cannabidiol from plant material |
| CN1809552A (zh) * | 2003-05-20 | 2006-07-26 | 田纳西大学研究基金会 | 大麻素衍生物、其制备方法和用途 |
| US7323576B2 (en) | 2004-10-01 | 2008-01-29 | Alphora Research Inc. | Synthetic route to dronabinol |
| TWI369203B (en) * | 2004-11-22 | 2012-08-01 | Euro Celtique Sa | Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol |
| DE102005028937B4 (de) * | 2005-06-22 | 2009-07-23 | Bionorica Ag | Verfahren zur Herstellung von Dronabinol |
| CA2623723A1 (en) * | 2005-09-29 | 2007-04-12 | Amr Technology, Inc. | Process for production of delta-9-tetrahydrocannabinol |
| CA2751741C (en) * | 2008-02-06 | 2018-07-10 | Mallinckrodt Inc. | Process for the preparation of (-) -delta 9-tetrahydrocannabinol |
| DE102009019322A1 (de) * | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
| PL3274321T3 (pl) * | 2015-03-23 | 2020-03-31 | Echo Pharmaceuticals B.V. | Izolat kannabidiolu z konopi przemysłowych i jego zastosowanie w preparatach farmaceutycznych i/lub kosmetycznych |
| CA2986268C (en) * | 2015-05-28 | 2024-01-02 | Insys Development Company, Inc. | Stable cannabinoid formulations |
| US10059683B2 (en) * | 2015-07-10 | 2018-08-28 | Noramco, Inc. | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol |
-
2016
- 2016-06-30 US US15/199,528 patent/US10059683B2/en active Active
- 2016-06-30 US US15/197,929 patent/US20170008869A1/en not_active Abandoned
- 2016-07-01 WO PCT/US2016/040635 patent/WO2017011210A1/en not_active Ceased
- 2016-07-01 ES ES20155338T patent/ES3010714T3/es active Active
- 2016-07-01 BR BR112018000497A patent/BR112018000497A2/pt not_active Application Discontinuation
- 2016-07-01 PT PT167414473T patent/PT3319952T/pt unknown
- 2016-07-01 JP JP2018520383A patent/JP6810842B2/ja active Active
- 2016-07-01 CA CA2992043A patent/CA2992043C/en active Active
- 2016-07-01 NZ NZ738925A patent/NZ738925A/en unknown
- 2016-07-01 MX MX2018000354A patent/MX2018000354A/es unknown
- 2016-07-01 DK DK16741447.3T patent/DK3319952T3/da active
- 2016-07-01 CN CN201680045030.1A patent/CN108137526A/zh active Pending
- 2016-07-01 EP EP16741447.3A patent/EP3319952B8/en active Active
- 2016-07-01 CR CR20180094A patent/CR20180094A/es unknown
- 2016-07-01 MY MYPI2018700102A patent/MY182971A/en unknown
- 2016-07-01 ES ES16741447T patent/ES2784881T3/es active Active
- 2016-07-01 EP EP20155338.5A patent/EP3722276B1/en active Active
- 2016-07-01 AU AU2016294264A patent/AU2016294264B2/en active Active
- 2016-07-01 HK HK18114529.1A patent/HK1255390A1/zh unknown
-
2018
- 2018-01-07 IL IL256750A patent/IL256750A/en unknown
- 2018-01-10 CL CL2018000079A patent/CL2018000079A1/es unknown
- 2018-01-10 PH PH12018500093A patent/PH12018500093A1/en unknown
- 2018-02-08 CO CONC2018/0001290A patent/CO2018001290A2/es unknown
- 2018-02-09 EC ECIEPI201810065A patent/ECSP18010065A/es unknown
- 2018-07-13 US US16/034,876 patent/US10844035B2/en active Active
-
2019
- 2019-09-13 AU AU2019229416A patent/AU2019229416A1/en not_active Abandoned
- 2019-11-04 CL CL2019003154A patent/CL2019003154A1/es unknown
- 2019-12-11 JP JP2019223998A patent/JP2020037596A/ja not_active Withdrawn
-
2020
- 2020-11-17 US US16/950,357 patent/US20210061781A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP18010065A (es) | Proceso para la producción de cannabidiol y delta-9-tetrahidrocannabinol | |
| DOP2021000179A (es) | Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
| MX2019011778A (es) | Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma. | |
| MX2015016947A (es) | Metodos para producir derivados de acido graso omega-hidroxilados. | |
| RU2012110715A (ru) | Способ получения микрокапсул | |
| MX2014015287A (es) | Derivado del ester del acido heteroarilcarboxilico. | |
| BR112014026053A2 (pt) | método de preparo de para-xileno a partir de biomassa | |
| AR101434A1 (es) | Método para producir (r)-1,1,3-trimetil-4-aminoindano | |
| CU24579B1 (es) | Proceso de preparación de una vacuna tetravalente atenuada contra el virus del dengue | |
| MX2015010584A (es) | Producción de cuero. | |
| BR112016013316A8 (pt) | método para a produção de furfural e uso de ácido metanossulfônico | |
| BR112013018703A2 (pt) | processo para a produção de óxido de etileno | |
| MX395589B (es) | Método para preparar derivado de oxaespirociclo e intermediario del mismo. | |
| BR112015029399A2 (pt) | produção em etapa única de uma composição de polipropileno | |
| MX2016000551A (es) | Proceso novedoso para la preparacion de pirrolidina-dionas espiroheterociclicas. | |
| BR112017001177A2 (pt) | processo para a purificação de poliovírus a partir de culturas celulares | |
| BR112016011899A2 (pt) | Processo para preparação de 5-fluoro-1h-pirazóis | |
| CL2017001383A1 (es) | Proceso para la fabricación de anhídrido carboxílico | |
| BR112016016397A2 (pt) | método para preparar 1-alquil-3-difluorometil-5-fluoro-1h-pirazol-4-carbaldeídos e 1-alquil-3-difluorometil-5-fluoro-1h-pirazol-4-carboxilatos. | |
| IN2014DN07656A (es) | ||
| MX353410B (es) | Tinturas ácidas, proceso para su producción y su uso. | |
| BR112015028751A2 (pt) | processo para a preparação de derivados de 3,5-bis (fluoralquil)pirazol a partir de alfa,alfa-dihaloaminas | |
| MX2016015871A (es) | Reaccion de prins en sustratos impedidos. | |
| MX2017001810A (es) | Metodo para obtener l-alanina cristalina. | |
| MX2016005222A (es) | Tinturas acidas, proceso para su produccion y su uso. |